Why Is Actis Continuing To Reduce Its Stake In Pine Labs?
Private equity firm Actis has continued its gradual exit from fintech company Pine Labs, offloading around a 2% stake worth ₹371 crore through a bulk deal on the BSE.
The latest transaction comes less than a week after the investor sold a smaller stake in the merchant commerce platform, indicating a phased monetisation strategy following Pine Labs’ public listing.
According to exchange data, Actis Pine Labs Investment Holdings Limited sold 2.39 crore shares at an average price of ₹155.17 per share, taking the total transaction value to approximately ₹371 crore.
The deal is one of the largest secondary market transactions in Pine Labs since the company’s stock market debut.
Who Bought The Pine Labs Shares?
Among the disclosed buyers, Axis Mutual Fund emerged as the largest institutional investor in the transaction.
The fund house acquired 96.15 lakh shares at ₹154 per share, investing around ₹148 crore in the fintech company.
The identities of the remaining institutional buyers were not immediately disclosed through the exchange filings.
The participation of large domestic institutional investors indicates continued interest in Pine Labs despite the ongoing stake sale by one of its early backers.
How Much Has Actis Sold So Far?
The latest sale follows another bulk deal executed just days earlier.
On June 19, Actis sold 98.28 lakh shares, representing around 0.86% of Pine Labs, at an average price of ₹154.25 per share, generating proceeds of ₹151.6 crore.
Combined with Wednesday’s transaction, Actis has now sold Pine Labs shares worth more than ₹522 crore within a span of a few trading sessions.
The staggered sale strategy allows the investor to gradually reduce its exposure while minimising market impact.
When Did Actis Invest In Pine Labs?
Actis first invested in Pine Labs in 2018, when it led an $82 million funding round that pushed the fintech company’s valuation close to the unicorn milestone.
Over the years, Pine Labs evolved into one of India’s leading merchant commerce and digital payments platforms, expanding across payment acceptance, merchant lending, billing, and financial services.
As of March 2026, Actis held a 4.48% stake in the company. Following the recent bulk deals, its shareholding has reduced further, although the revised holding has not yet been officially disclosed.
How Is Pine Labs Performing Financially?
Pine Labs has shown a significant improvement in financial performance following its public listing.
For the fourth quarter of FY26, the company reported a 17% year-on-year increase in revenue, with operating income rising to ₹700.5 crore from ₹598.6 crore in the corresponding quarter of the previous year.
More importantly, Pine Labs returned to profitability during the quarter, posting a net profit of ₹59.4 crore compared with a net loss of ₹28.9 crore a year earlier.
The turnaround was supported by continued revenue growth, improving operating efficiencies, and disciplined cost management.
What Does This Mean For Pine Labs Investors?
Large private equity investors often reduce their holdings gradually after portfolio companies become publicly listed as part of their normal investment lifecycle.
Actis’ latest transaction appears to be a continuation of that strategy rather than a reflection of Pine Labs’ operating performance.
Meanwhile, the participation of institutional investors such as Axis Mutual Fund suggests confidence in the company’s long-term growth prospects.
At Wednesday’s market close, Pine Labs shares settled at ₹161.25, valuing the fintech company at approximately ₹18,516 crore (around $1.95 billion).
With improving profitability, sustained revenue growth, and increasing institutional participation, Pine Labs continues to remain one of India’s closely watched listed fintech companies even as early investors gradually monetise their holdings.
